Trials / Recruiting
RecruitingNCT05794425
Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders
A Multicenter Collaborative Clinical Study of Umbilical Cord Blood Combined With Umbilical Cord Derived Mesenchymal Stem Cells in the Treatment of Bone Marrow Failure Disorders
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Shandong Qilu Stem Cells Engineering Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The multicenter collaborative clinical study conducted a systematic clinical observation in the treatment of bone marrow failure diseases via UCB\&UC-MSCs , in order to observe its clinical efficacy and safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cyclosporine A | 3-5 mg per kilogram per day. |
| BIOLOGICAL | Umbilical cord blood & Umbilical cord derived mesenchymal stem cells | Intravenous infusion of umbilical cord blood and umbilical cord derived mesenchymal stem cells (5-8×10\^7) at 1 week interval. |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2025-04-01
- Completion
- 2026-04-01
- First posted
- 2023-04-03
- Last updated
- 2023-11-29
Locations
8 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05794425. Inclusion in this directory is not an endorsement.